uniQure QURE EBIT

EBIT at other companies

Sarepta Therapeutics, Inc.SRPT

$13.29M-88.5%

Taysha Gene Therapies, Inc.TSHA

-$43.49M-103%

PTC TherapeuticsPTCT

$44.96M-95.4%

Design Therapeutics, Inc.DSGN

-$19.71M+3.5%

Candel Therapeutics, Inc.CADL

-$16.28M-100%

RegenxbioRGNX

$29.26M+146%

FAQ

What is uniQure's EBIT?

uniQure (QURE) reported EBIT of -$52.2M in Q2 2026.

How has uniQure's EBIT changed year-over-year?

uniQure's EBIT decreased by 19.0% year-over-year, from -$43.87M to -$52.2M.

What is the long-term trend for uniQure's EBIT?

Over 4 years (2021 to 2025), uniQure's EBIT has grown at a -12.1% compound annual growth rate (CAGR), from $310.62M to -$185.35M.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.